Clorox Company (CLX) has seen pronounced investment activity with entities such as
Virtu Financial LLC,
Aigen Investment Management LP, and
CCM Investment Group LLC establishing new positions while others, like
Nuance Investments LLC and
Jefferies Financial Group Inc., reduced their holdings.
Institutional investors, like the National Bank of Canada, Deutsche Bank AG, and Russell Investments Group have increased their stakes. Despite a
37% loss from investing in the stock five years ago, its prospects have been enhanced by international expansion considered crucial for the company's long-term success. A turning point might be in sight, underscored by diluted bullishness, however, the persisting trend of lowered price targets, particularly by J.P. Morgan, is a concern. Amid market turmoil, CLX hit its
52-week low at $125.66. The company's
innovation strategy continues to elevate its product portfolio, promising dividends to shareholders amid market volatility. Despite beating FQ1 expectations, Clorox has provided a lackluster full-year guidance. Notably, Clorox's CFO Kevin Jacobsen announced retirement, succeeded by Luc Bellet.
Clorox Company CLX News Analytics from Sun, 19 Jan 2025 08:00:00 GMT to Sat, 16 Aug 2025 13:23:34 GMT -
Rating 3
- Innovation -5
- Information 7
- Rumor -6
